Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48:13–18
2011 ◽
Vol 185
(4)
◽
pp. 1302-1303
◽
2015 ◽
Vol 48
(1)
◽
pp. 13-18
◽
2010 ◽
Vol 170
(17)
◽
pp. 1586-1593
◽
2006 ◽
Vol 9
(1)
◽
pp. 44
◽
2018 ◽
Vol 25
(8)
◽
pp. 710-715
◽
2018 ◽
Vol 25
(2)
◽
pp. 91-95
◽